Serum uric acid as a surrogate marker of favorable response to bevacizumab treatment in patients with metastatic colon cancer için istatistikler

Toplam ziyaret

views
Serum uric acid as a surrogate marker of favorable response to bevacizumab treatment in patients with metastatic colon cancer 0

Aylık toplam ziyaret

views
Aralık 2025 0
Ocak 2026 0
Şubat 2026 0
Mart 2026 0
Nisan 2026 0
Mayıs 2026 0
Haziran 2026 0

Dosya Ziyaretleri

views
Bilici, Ahmet.pdf 4